Skip to main content
. 2017 Nov 27;14(3):596–608. doi: 10.1080/21645515.2017.1384106

Table 5.

HAI GMTs at baseline and day 21 by previous year's vaccination.

      HAI GMT (95% CI)
      A/H1N1
A/H3N2
B Victoria lineage
B Yamagata lineage
Age Vaccine Day Vaccinated previous year Not vaccinated previous year Vaccinated previous year Not vaccinated previous year Vaccinated previous year Not vaccinated previous year Vaccinated previous year Not vaccinated previous year
18–60 y Pooled IIV4   N = 173 N = 659 N = 173 N = 658 N = 173 N = 658 N = 173 N = 658
    0 169 (138, 206) 47.8 (42.2, 54.2) 160 (130, 198) 35.5 (31.4, 40.1) 156 (129, 189) 47.8 (42.8, 53.5) 532 (448, 633) 187 (167, 210)
    21 355 (305, 413) 701 (644, 764) 395 (338, 461) 530 (482, 583) 495 (424, 578) 779 (721, 842) 1077 (933, 1244) 1938 (1806, 2080)
  Pooled IIV3   N = 60 N = 218 N = 60 N = 218 N = 36 N = 104 N = 24 N = 114
    0 160 (113, 228) 52.4 (42.2, 65.2) 147 (104, 208) 29.9 (24.4, 36.6) 171 (112, 261) 46.0 (34.7, 61.0) 570 (344, 944) 246 (187, 325)
    21 365 (274, 488) 815 (684, 971) 387 (282, 532) 719 (611, 846) 484 (346, 677) 850 (692, 1044) 973 (657, 1441) 1959 (1673, 2294)
>60 y Pooled IIV4   N = 404 N = 424 N = 404 N = 423 N = 403 N = 424 N = 404 N = 423
    0 76.9 (67.4, 87.7) 26.0 (22.5, 30.0) 113 (99.2, 129) 36.9 (31.3, 43.5) 100 (89.2, 113) 39.2 (33.7, 45.6) 274 (248, 304) 94.5 (82.1, 109)
    21 176 (156, 197) 270 (232, 314) 275 (247, 306) 462 (406, 525) 221 (198, 246) 367 (327, 412) 509 (464, 558) 835 (758, 921)
  Pooled IIV3   N = 131 N = 143 N = 131 N = 142 N = 66 N = 71 N = 65 N = 72
    0 86.4 (67.9, 110) 24.2 (18.8, 31.2) 143 (114, 180) 37.5 (28.0, 50.3) 97.7 (76.0, 125) 45.0 (30.0, 67.5) 300 (232, 389) 101 (69.7, 147)
    21 173 (142, 212) 399 (316, 504) 305 (254, 367) 543 (432, 683) 190 (153, 237) 459 (329, 640) 462 (368, 580) 1011 (830, 1232)

Values are for all participants vaccinated with available pre- and post-vaccination HAI titers. Abbreviations: CI, confidence interval; GMT, geometric mean titer; HAI, hemagglutination inhibition; IIV3, trivalent inactivated influenza vaccine; IIV4, quadrivalent inactivated influenza vaccine.